Related Experiment Videos
Leucopenia--an unusual presenting feature in primary systemic vasculitis
British Journal of Rheumatology
|May 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinoma.
Nature communications·2026
Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.
Acta neurologica Scandinavica·2016
High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis.
Acta neurologica Scandinavica·2015
A case of systemic nocardiosis in systemic vasculitis and a review of the literature.
Singapore medical journal·2013
Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.
British journal of rheumatology·1999
Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.
British journal of rheumatology·1999
Circulating interleukin-16 in systemic lupus erythematosus.
British journal of rheumatology·1999
Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.
British journal of rheumatology·1999
Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.
British journal of rheumatology·1999
A study of the frequency of pericardial and pleural effusions in scleroderma.
British journal of rheumatology·1999
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026